Clinical trial Recruiting at 1 site Interventional Ages 12 to 18

Mediterranean and Low-Histamine Diets for pediatric chronic spontaneous urticaria

Official title: The Effects of the Mediterranean and Low-Histamine Diets on Disease Severity in Pediatric Chronic Spontaneous Urticaria

Run by Saglik Bilimleri Universitesi · NCT07765979 · Data updated 2026-11-12

This study tests whether adding a Mediterranean diet or a low-histamine diet to standard care helps 12- to 18-year-olds with chronic spontaneous urticaria feel better and have fewer symptoms.

Quick facts

Study typeInterventional
Ages12 Years to 18 Years
SexAll
Enrollment63 (estimated)
SponsorSaglik Bilimleri Universitesi
Academic / other
Locations1 site (Istanbul, Istanbul)
StatusRecruiting
StartedNovember 23, 2025
Main results expectedJanuary 15, 2027
Study endsJanuary 15, 2027
Registry record updatedSeptember 4, 2026
Trial IDNCT07765979 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ages 12-18 with chronic spontaneous urticaria, not recently on systemic corticosteroids or immunosuppressive therapy (except short-term use), and who can provide informed consent.

Probably not a fit

Patients with other chronic diseases, neurodevelopmental disorders, or those requiring a special therapeutic diet may not benefit, and those with recent or persistent use of certain medications or acute infections are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized, three-arm trial compares standard treatment alone to standard treatment plus a Mediterranean diet or plus a low-histamine diet in adolescents with chronic spontaneous urticaria. The dietary interventions run for four weeks, with assessments at baseline and week four. Outcomes include disease activity (UAS7), disease control (UCT), and quality of life (CDLQI and DLQI), along with a diet quality index for children and adolescents. The study aims to determine which dietary approach, if either, provides greater benefit alongside standard therapy. Participants are 12–18 years old and must meet specific clinical criteria and provide informed consent.

Why it matters

Potential benefit: If successful, the dietary approaches could offer an additional way to reduce symptoms and improve quality of life for young people with CSU.

How similar studies have gone: There is limited direct evidence from pediatric trials comparing Mediterranean and low-histamine diets for CSU; this study addresses that gap with a randomized design.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age 12-18 years.
* Confirmed diagnosis of Chronic Spontaneous Urticaria (CSU) according to international guidelines.
* No recent use of systemic corticosteroids or immunosuppressive therapy (except short-term acute use).
* Written informed consent provided by both the participant and a parent/legal guardian.

Exclusion Criteria:

* Presence of a neurodevelopmental disorder.
* Presence of any other known chronic disease.
* Presence of a disease requiring a special therapeutic diet.
* Presence of an acute infection.
* Presence of any food allergy.
* Recent use of systemic corticosteroids, biologic agents, - immunosuppressive therapy, or high-dose antihistamines (except short-term acute use).

Where it's running

  • T.C. İstanbul Prof. Dr. Cemil Taşcıoğlu Şehir Hastanesi
    Istanbul, Istanbul, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.